DNA vaccine against hamster oral papillomavirus-associated oral cancer

Journal of International Medical Research

Volumn 33, Issue 6, 2005, Pages 647-653

  Maeda, H ^a   Kubo, K ^a   Sugita, Y ^a   Miyamoto, Y ^a   Komatsu, S ^a   Takeuchi, S ^a   Umebayashi, T ^a   Morikawa, S ^a   Kawanishi, K ^a   Kameyama, Y ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

9,10 dimethyl 1,2 benzanthracene; DNA vaccine; Hamster; Human papillomavirus; L1 region; Oral cancer

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; DNA VACCINE; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOLOGY; CANCER PREVENTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; HAMSTER; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; MALE; MOUTH CANCER; NONHUMAN; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; VIRUS CARCINOGENESIS; VIRUS INFECTION;

EID: 29444457529     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300606     Document Type: Article

References (11)

1. Maeda H, Kameyama Y: Effect of excisional wounding on DMBA-induced hamster tongue carcinogenesis. J Oral Pathol 1986; 15: 21-27.
2. Maeda H, Kameyama Y, Nakane S, Takehana S, Sato E: Epithelial dysplasia produced by carcinogen pretreatment and subsequent wounding. Oral Surg Oral Med Oral Pathol 1989; 68: 50-56.
3. Fujita K, Kameyama Y, Maeda H, Tanaka H, Konishi S, Kato H, et al: Immunohistochemical and ultrastructural studies of experimental epithelial dysplasia induced by excisional wounding and Trp-P-2 application in hamster tongues. Oral Med Pathol 1997; 2: 75-80.
4. Iwasaki T, Maeda H, Kameyama Y, Moriyama M, Konai S, Kurata T: Presence of a novel hamster oral papillomavirus in dysplastic lesions of hamster lingual mucosa induced by application of dimethylbenzanthracene and excisional wounding: molecular cloning and complete nucleotide sequence. J Gen Virol 1997; 78: 1087-1093.
5. Donnelly JJ, Martinez D, Jansen KU, Ellis RW, Montgomery DL, Liu MA: Protection against papillomavirus with a polynucleotide vaccine. J Infect Dis 1996; 173: 314-320.
6. Sundaram P, Tigelaar RE, Brandsma JL: Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge. Vaccine 1997; 15: 664-671.
7. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-1749.
8. Ji H, Wang TL, Chen CH, Pai SI, Hung CF, Lin KY, et al: Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther 1999; 10: 2727-2740.
9. Kim JW, Hung CF, Juang J, He L, Kim TW, Armstrong DK, et al: Comparison of HPV DNA vaccines employing intracellular targeting strategies. Gene Ther 2004; 11: 1011-1018.
10. Rocha-Zavaleta L, Alejandre JE, Garcia-Carranca A: Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses. J Med Virol 2002; 66: 86-95.
11. Schreckenberger C, Sethupathi P, Kanjanahaluethai A, Muller M, Zhou J, Gissmann L, et al: Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization. Vaccine 2001; 19: 227-233.